Loss of fragile histidine triad protein in human hepatocellular carcinoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

252

HTML

1785

Figures (1-1)

215

Tables (1-2)

180

Sum=2432

Jun 15, 2003 (publication date) through Nov 5, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. Jun 15, 2003; 9(6): 1216-1219
Published online Jun 15, 2003. doi: 10.3748/wjg.v9.i6.1216

Table 1 Levels of Fhit expression in heptocellular carcinomas, para-neoplastic tissues and normal liver tissues

^bP = 0.000, vs hepatocellular carcinomas.

Citation: Zhao P, Song X, Nin YY, Lu YL, Li XH. Loss of fragile histidine triad protein in human hepatocellular carcinoma. World J Gastroenterol 2003; 9(6): 1216-1219
URL: https://www.wjgnet.com/1007-9327/full/v9/i6/1216.htm
DOI: https://dx.doi.org/10.3748/wjg.v9.i6.1216